Form4insider filings, from the source

SEC Form 4 · accession 0000902664-17-002551

PUMA BIOTECHNOLOGY, INC. · PBYI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Phillip Gross
10% Owner
Period of report
Jun 1, 2017
Accepted (ET)
Jun 5, 2017 · 5:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401667

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.0001 ("Common Stock")F1,F2Jun 1, 2017S164,325$82.4112D4,286,643ISee footnote
Common StockF3,F2Jun 1, 2017S5,200$83.5454D4,281,443ISee footnote
Common StockF4,F2Jun 2, 2017S30,475$83.0611D4,250,968ISee footnote
Common StockF5,F2Jun 5, 2017S1,100$85.3182D4,249,868ISee footnote
Common StockF6,F2Jun 5, 2017S63,227$88.1235D4,186,641ISee footnote
Common StockF7,F2Jun 5, 2017S152,762$90.2132D4,033,879ISee footnote
Common StockF8,F2Jun 5, 2017S23,272$91.3138D4,010,607ISee footnote
Common StockF2Jun 5, 2017S3,083$92.00D4,007,524ISee footnote
Common StockF9,F2Jun 5, 2017S52,016$96.6144D3,955,508ISee footnote
Common StockF10,F2Jun 5, 2017S11,668$99.0798D3,943,840ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses